About the MDMA-Assisted Therapy Education Program

MDMAassisted therapy has not been approved by any regulatory agency. The safety and efficacy of MDMA-assisted therapy have not been established for the treatment of PTSD.

Immersion Course

Our immersion course consists of live presentations, video case presentations, enriching discussions, scenario-based learning, self-reflection, small group, dyad activities, online coursework, and creative projects. The live education component is led by educators who have worked on our MDMA-assisted therapy clinical trials and provides a container for discussion, in-depth inquiry, experiential learning, and personal growth.  

In 2023, this Immersion course is offered in three different formats: virtual, in-person, and hybrid. Dates and details will be added to this webpage soon.  

By the end of this course, attendees will be able to:  

  1. Understand the fundamental processes and concepts underlying investigational MDMA-assisted therapy   
  2. Consider the role of identity and culture in therapeutic alliance and trauma processing  
  3. Translate the concepts of inner healing intelligence and inner-directed therapeutic approach to their work with clients  
  4. Strengthen the therapeutic alliance with clients  
  5. Engage in personal growth practices that enable grounding, self-care, and sustainability  
  6. Engage with a growing network of MDMA-assisted therapy informed professionals through continuing educational opportunities, community building, and opportunities for scientific discussion 

Please note this is not a certification course to deliver MDMA-assisted therapy. There are currently no certification standards for any psychedelic-assisted therapy given the investigational status of this modality, which has not been approved by the U.S. Food and Drug Administration (FDA) or any regulatory authority. There are no guarantees about the approval of MAPS PBC’s New Drug Application for MDMA-assisted therapy to the FDA or the specific certification requirements for healthcare providers should this be approved. Given the uncertainty of the regulatory process and timeline, there may be a significant delay and no guarantee of opportunities to practice MDMA-assisted therapy in clinical practice.

2023 Education Events

Our 2023 Education Events will be offered in two formats:

  • Fully virtual (6 virtual live sessions via Zoom)
  • Hybrid (2 virtual live sessions via Zoom + 4.5 consecutive days in-person)

All formats include self-paced asynchronous online coursework to be completed before the live sessions.


  1. Fall Virtual Immersion:
      • Online course launches September 23rd
      • Live Virtual Sessions October 7th – 9th, November 10th – 12th
  2. Fall Hybrid Immersion:
      • Online course launches September 30th
      • Live Virtual Sessions October 14th – 15th
      • In-Person Session at Usona Institute in Wisconsin November 8th – 12th

Application Criteria

Candidates for the MDMA-Assisted Therapy Education Program must meet both of the following eligibility criteria: 

  • Hold an active medical or clinical license or are on track to obtain licensure through an advanced degree program or post-graduate professional experience
  • Completed or enrolled in specialty training in mental health OR demonstrate a minimum of 1,000 hours of experience providing behavioral health services 

These qualifications outline the minimum requirements for the program. The Admissions Committee will consider the years of experience, education, and capabilities. We value a diverse range of professional, spiritual, and traditional backgrounds. Currently, the MDMA-Assisted Therapy Education Program prioritizes licensed applicants who practice psychotherapy. We strive to enroll compassionate and experienced trauma clinicians committed to health and well-being, their own and that of their clients and community.  

In this trauma-focused education course, attendees will be exposed to a wide range of clinical trial video footage involving participants suffering from diverse trauma forms. Some content may be challenging to view and potentially triggering. We ask prospective attendees to consider whether this course is right for them. 

Please note that the 2023 application is not open to international applicants.  This year, the program is only open to applicants who live and work in the US and US territories.

The application is now closed for our Fall 2023 events. The MDMA-Assisted Therapy Education Program will provide updates on this webpage about upcoming education opportunities as they become available.

For inquires about the MDMA-Assisted Therapy Education program, please email [email protected].


Tuition for the 2023 MDMA-Assisted Therapy Education Program is $3,500. Additional fees for lodging and accommodation for Hybrid events are not included in the tuition cost.

Collaboration Opportunities

As we continue to build the MDMA-Assisted Therapy Education Program, we welcome opportunities to work with other organizations interested in facilitating education about investigational MDMA-assisted therapy, including:   

  • Graduate education programs in psychotherapy, psychiatry, nursing, and related fields   
  • Private education organizations that teach clinical and psychological theories or modalities   
  • Behavioral health care organizations   
  • Professional associations and advocacy groups   

There are a variety of ways in which we can collaborate, including the delivery of our Immersion course to different audiences. If you are interested in exploring a collaboration, please contact us at [email protected].  

Sign Up for Our Newsletter

Come join our growing community and sign up to receive news about upcoming MDMA-Assisted Therapy Education Program opportunities, Health Equity scholarship updates, and other news from the growing field of psychedelic medicine.

MAPS Public Benefit Corporation

Our Mission
Who We Are
Contact Us
Privacy Policy

Cookie Policy

3141 Stevens Creek Blvd #40547
San Jose, CA 95117

MAPS PBC is a wholly-owned subsidiary of the Multidisciplinary Association for Psychedelic Studies (MAPS). MAPS is a 501(c)(3) non-profit research and educational organization.

Stay Up-to-Date about the MDMA-AT Education Program

You have Successfully Subscribed!